Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1371876 | Bioorganic & Medicinal Chemistry Letters | 2009 | 5 Pages |
A series of substituted biphenyl ethylene ether compounds has been designed to target the gp41 N-trimer in order to inhibit formation of the six-helical bundle that represents the end state of gp41-mediated viral fusion. A size exclusion HPLC based helical bundle formation (HBF) assay was developed to evaluate in vitro inhibitory affinity of the inhibitors. The most potent compound 1 had an IC50 of 31 μM. The binding of compound 1 to the proposed hydrophobic pocket of gp41 was further validated by site-directed peptide mutagenesis experiments.
Graphical abstractStructure-based design of small molecule ligands binding in the hydrophobic pocket of gp41 and blocking the helical bundle formation is described.Figure optionsDownload full-size imageDownload as PowerPoint slide